ClinicalTrials.gg

Assembly Biosciences clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 30 studies whose lead sponsor is Assembly Biosciences or one of 1 company grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Assembly Biosciences with Mirum Pharmaceuticals and Vir Biotechnology →

Pipeline: 1 program

Each counted once: 1 with a study Assembly Biosciences leads registered in the last two years.

  • Phase 2

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Assembly Biosciences’ own registered studies; Assembly Biosciences’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Assembly Biosciences’ studies test, most open studies first — 6 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Assembly Biosciences’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 30 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now27%
  • Completed1860%
  • Stopped early723%
  • Status unknown or other310%

Phase

  • Phase 119
  • Phase 210
  • Phase 32

Where

  • United States17
  • New Zealand17
  • Hong Kong7
  • Australia6
  • Canada6
  • United Kingdom6

Over the years

  1. 11
  2. 12
  3. 413
  4. 14
  5. 15
  6. 16
  7. 17
  8. 18
  9. 19
  10. 20
  11. 21
  12. 22
  13. 23
  14. 24
  15. 25
  16. 226

By the year each study started; 1 started before 2011. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Assembly Biosciences.

  • Assembly Biosciences
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    23 studies
  • Ventrus Biosciences, Inc
    Acquired — became part of Assembly Biosciences, Jul 11, 2014 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →

Focus areas

Conditions Assembly Biosciences leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 30 of 30.